2021
DOI: 10.30654/mjcr.10068
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and Sudden Cardiac Death in a Young Man with Myasthenia Gravis

Abstract: Myasthenic patients are expected to develop more severe COVID-19 respiratory symptoms compared to the general population because of both respiratory muscle weakness and the possibility of an immunocompromised state related to immunotherapy. During a pandemic like COVID-19, such situation requires meticulous attention, as the entire population is potentially at risk of exposure. However, there is no data on best management for myasthenic patients with COVID infection.Although pneumonia has been reported as the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 17 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?